SUHAGRA DURALONG (Spray)

What is SUHAGRA DURALONG (Spray)?

SUHAGRA DURALONG (Spray) is a topical agent for men, designed to temporarily reduce excessive sensitivity of the penis. The product is manufactured in the form of a spray, which facilitates the application of a small amount of the agent directly onto the target area. Its use can contribute to better control of the moment of ejaculation and increase the duration of sexual intercourse. The product belongs to the category of topical prolongators.

The basis of its action is local anesthesia, meaning the reversible weakening of the sensitivity of nerve endings at the site of application. SUHAGRA DURALONG (Spray) does not eliminate psychological, urological, or hormonal causes of premature ejaculation and does not replace a comprehensive diagnosis. The effect is temporary and depends on the amount applied, waiting time, and individual response of the body. Excessive use can cause overly pronounced numbness and decrease the quality of sexual contact.

The manufacturer of SUHAGRA DURALONG (Spray) is the pharmaceutical company Cipla. Before the first use, it is necessary to check the composition and dosage on the packaging and in the official instructions of the specific batch, as product characteristics for different markets may vary. The product is intended for external use by adult men and is not a contraceptive. It also does not protect against sexually transmitted infections.

What is SUHAGRA DURALONG (Spray) prescribed for?

The main indication is premature ejaculation, where ejaculation regularly occurs earlier than desired and causes discomfort to one or both partners. SUHAGRA DURALONG (Spray) locally reduces the sensitivity of the glans penis, thereby potentially prolonging the time to ejaculation. The product should be considered as symptomatic help rather than a treatment for the root cause of the disorder. If the problem arose suddenly, persists for a long time, or is accompanied by pain or erectile dysfunction, a consultation with a urologist or sexologist is required.

SUHAGRA DURALONG (Spray) can be used to improve ejaculation control in men with increased local sensitivity. Reducing the intensity of sensory signals sometimes helps to reduce the haste of sexual intercourse and the associated tension. At the same time, the drug does not increase testosterone levels, does not enhance sexual desire, and does not treat erectile dysfunction. To achieve the effect, sexual stimulation and preserved physiological capacity for erection are necessary.

Before use, it is important to distinguish episodic early ejaculation from a persistent disorder. Consulting a doctor before use is especially necessary in the presence of chronic diseases, allergies to local anesthetics, or when taking other drugs. A comprehensive approach may include behavioral techniques, psychotherapy, and treatment of concomitant urological conditions. The result of application is not the same for all men, as the body's response is individual.

Composition and active components of SUHAGRA DURALONG (Spray)

The active component of SUHAGRA DURALONG (Spray), according to the product information, is lidocaine — an amide-type local anesthetic. It temporarily blocks sodium channels in the membranes of nerve fibers and slows down the transmission of pain and tactile impulses. In simple terms, the treated area becomes less sensitive, which can delay the ejaculatory reflex. The action is local, provided it is correctly applied to intact skin and the recommended amount is observed.

Excipients ensure spraying, even distribution, and stability of the preparation. Their exact list, as well as the concentration of lidocaine, should be checked on the packaging and in the instructions of SUHAGRA DURALONG (Spray), as the composition may depend on the form of supply. An alcohol-based or aromatic base sometimes causes burning, dryness, or contact irritation. In case of known sensitivity to any component, the product must not be used.

Dosage of SUHAGRA DURALONG (Spray)

It is dangerous to establish a universal number of sprays without taking into account the concentration of lidocaine, so the dosage from the official instructions of the specific bottle should be used. For the first application of SUHAGRA DURALONG (Spray), it is advisable to choose the lowest recommended dose. The product is applied in a thin layer only on areas of increased sensitivity, not exceeding the maximum single and daily amount. Adding new sprays due to an insufficient instant effect is not recommended, as the action of lidocaine develops gradually.

SUHAGRA DURALONG (Spray) is usually used situationally before sexual contact, rather than as a continuous course drug. Daily prolonged use without medical supervision is not recommended due to the risk of irritation, reduced sensitivity, and excessive absorption of the anesthetic. Dose adjustment may be required for elderly men, people with liver diseases, heart rhythm disorders, or skin damage. In such cases, the regimen should be determined by a doctor.

If the minimum recommended amount causes pronounced numbness, burning, or weakening of erection due to loss of sensitivity, the dose is not increased. The excess product must be carefully removed, and the skin rinsed with water in accordance with the instructions. If there is no effect after several correctly performed applications, it is necessary to consult a specialist rather than experiment with dosage. Frequent uncontrolled use can mask a condition that requires other treatment.

How to properly take SUHAGRA DURALONG (Spray)?

SUHAGRA DURALONG (Spray) is not taken orally: it is sprayed externally on clean, dry, and undamaged skin of the glans penis according to the instructions. After application, wait the time specified by the manufacturer for the product to take effect. Before sexual contact, it is recommended to thoroughly wash off or remove the remnants of the product to reduce the transfer of lidocaine to the partner. After the procedure, it is necessary to wash hands and avoid contact of the product with eyes, mouth, and mucous membranes.

Food intake does not significantly affect the local action of SUHAGRA DURALONG (Spray), as the product is not intended for swallowing. It should not be applied to inflamed, injured, or infected skin, or immediately after procedures that can cause micro-damage. To reduce anesthetic transfer, a condom can be used, after checking the compatibility of the material with the spray components. Getting the product into the partner's genital tract can cause numbness and reduced sensitivity.

The concept of a missed dose does not apply to a situational drug. If SUHAGRA DURALONG (Spray) was not applied in time, there is no need to compensate with a double amount. The product should not be sprayed near an open fire or heat sources if its base is flammable. Before use, consultation with a doctor and careful reading of the instructions are mandatory.

Side effects of SUHAGRA DURALONG (Spray)

The most common local reactions include short-term numbness, tingling, burning, redness, dryness, or skin irritation. Excessive reduction in sensitivity can make it difficult to maintain an erection or reduce pleasure from sexual contact. The partner may experience numbness of the mucous membranes in case of transfer of the product. Usually, mild manifestations disappear after removing the product, but repeated application on the same day is undesirable.

Contact dermatitis, rash, itching, or swelling occur uncommonly. Rare systemic reactions are possible with overdose, application to a large area or damaged skin, and may include dizziness, drowsiness, tinnitus, visual impairment, tremors, or palpitations. Pronounced weakness, confusion, convulsions, or heart rhythm disorders require emergency medical attention. Further use of SUHAGRA DURALONG (Spray) is discontinued until evaluated by a doctor.

Swelling of the face or throat, difficulty breathing, and generalized hives may indicate a severe allergic reaction. With such symptoms, it is necessary to immediately call emergency help. The intensity of adverse events depends on the dose, skin condition, and individual sensitivity. Even with previous good tolerance, the body's reaction during the next application may differ.

Contraindications of SUHAGRA DURALONG (Spray)

An absolute contraindication is an allergy to lidocaine, other amide-type local anesthetics, or excipients. SUHAGRA DURALONG (Spray) is not applied to open wounds, ulcers, active inflammation, or infected areas. The product is not used if the partner has a known allergy to lidocaine and contact cannot be reliably prevented. Accidental swallowing of the drug is unacceptable.

Relative contraindications are severe liver diseases, heart failure, bradycardia, heart conduction disorders, and a predisposition to methemoglobinemia — a condition in which the blood carries oxygen less effectively. Caution is required when using other local anesthetics simultaneously. In the presence of chronic diseases, the decision on use is made by a doctor. It is also necessary to consider all drugs that a man takes constantly or periodically.

SUHAGRA DURALONG (Spray) is not intended for children, adolescents, and women, particularly during pregnancy or breastfeeding. A pregnant partner should not contact the applied drug without prior consultation with a doctor. Elderly men may need special caution due to slower elimination of lidocaine and concomitant cardiovascular diseases. Age restrictions must be checked with the official instructions.

Interaction of SUHAGRA DURALONG (Spray) with other drugs and alcohol

Systemic absorption with proper local use is usually small, but interactions are possible if the dose is exceeded. Caution is required with antiarrhythmic drugs, other products containing lidocaine, local anesthetics, some beta-blockers, and drugs that slow down hepatic metabolism. The combination may increase the concentration of lidocaine and the risk of neurological or cardiac reactions. Before using SUHAGRA DURALONG (Spray), you should inform your doctor about all medicines and supplements.

Alcohol does not have a direct beneficial interaction with the spray and can impair ejaculation control, erection, coordination, and the ability to estimate the dose. Therefore, the consumption of alcoholic beverages before use is better to be restricted or eliminated. In the absence of dizziness or visual impairment, the topical agent usually does not affect the ability to drive vehicles. If drowsiness, weakness, or other systemic symptoms occur, driving and operating machinery is prohibited.

Where to buy SUHAGRA DURALONG (Spray) in Ukraine

SUHAGRA DURALONG (Spray) in Ukraine can be searched for in licensed pharmacies and verified online pharmacy services, after checking the legality of circulation and the presence of proper labeling. Before buying, it is worth checking the manufacturer Cipla, packaging integrity, batch, expiration date, composition, and presence of instructions. Dispensing conditions and availability may change, so they should be verified in a specific pharmacy. You should not buy the drug from hands or on resources that do not provide information about the origin of the product.

Store SUHAGRA DURALONG (Spray) in its original packaging, at the temperature specified by the manufacturer, away from the sun, heating appliances, and children. The aerosol can must not be punctured, heated, or left near an open flame. During delivery, it is important to comply with temperature requirements and not to accept damaged packaging. The description is for informational purposes: before use, consultation with a doctor is necessary, and the final decision is made taking into account the individual response of the body and the official instructions.